Aaron C.W. Lasker, MD
Assistant Professor of Clinical Neurology
Director, HDSA Huntington's Disease Center of Excellence, University of Pennsylvania
Department: Neurology
Contact information
330 S 9th Street
3rd floor
Philadelphia, PA 19107
3rd floor
Philadelphia, PA 19107
Office: 215.829.6500
Fax: 215.829.6606
Fax: 215.829.6606
Links
Interview regarding Parkinson's disease and palliative care
University of Pennsylvania Huntington's Disease Center, Director
Interview regarding Parkinson's disease and palliative care
University of Pennsylvania Huntington's Disease Center, Director
Education:
B.Sc (Neuroscience)
Brown University, Providence, RI, 2007.
MD (Neurology)
Tufts University School of Medicine, Boston, MA, 2013.
B.Sc (Neuroscience)
Brown University, Providence, RI, 2007.
MD (Neurology)
Tufts University School of Medicine, Boston, MA, 2013.
Post-Graduate Training
Internship for Internal Medicine, Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI, 2013-2014.
Residency in Neurology, Harvard Neurology Residency Program at Beth Israel Deaconess Medical Center, Boston, MA, 2014-2017.
Fellowship in Cognitive Neurology, Harvard Neurology Residency Program at Beth Israel Deaconess Medical Center Boston, MA, 2017-2018.
Fellowship in Movement Disorders, Harvard Neurology Residency Program at Beth Israel Deaconess Medical Center Boston, MA, 2017-2018.
Internship for Internal Medicine, Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI, 2013-2014.
Residency in Neurology, Harvard Neurology Residency Program at Beth Israel Deaconess Medical Center, Boston, MA, 2014-2017.
Fellowship in Cognitive Neurology, Harvard Neurology Residency Program at Beth Israel Deaconess Medical Center Boston, MA, 2017-2018.
Fellowship in Movement Disorders, Harvard Neurology Residency Program at Beth Israel Deaconess Medical Center Boston, MA, 2017-2018.
Certifications
American Board of Psychiatry and Neurology, Board Certified Neurologist , 2017.
Permanent linkAmerican Board of Psychiatry and Neurology, Board Certified Neurologist , 2017.
Description of Clinical Expertise
Movement Disorders Specialist with an interest in Huntington's disease and Parkinson's disease. Special interest in cognition, non-motor symptoms and neuropalliative care. clinical administration of botulinum toxin injections.Selected Publications
Deik A, Aamodt W, Cadet C, Lasker A, Oliver A, Spindler M, Tropea TF, Vaswani P, Siderowf A.: An open-label pilot study to examine the safety, tolerability and efficacy of deutetrabenazine inisolated dystonia. Movement Disorders Clinical Practice Jan 2025 Notes: doi: 10.1002/mdc3.14327. Online ahead of print.C. Marshall, W. Aamodt, J. Klapper, P. Cinicola, N. Kleinberg, A. Lasker : Patient Reported Outcomes of Using a Chaplain Service in a Huntington’s Disease Clinic. Movement Disorders Society, Annual Congress 2024, Philadelphia PA Sep 2024 Notes: https://www.mdsabstracts.org/abstract/patient-reported-outcomes-of-using-a-chaplain-service-in-a-huntingtons-disease-clinic/
Tropea TF, Hartstone W, Amari N, Baum D, Rick J, Suh E, Zhang H, Paul RA, Han N, Zack R, Brody EM, Albuja I, James J, Spindler M, Deik A, Aamodt WW, Dahodwala N, Hamedani A, Lasker A, Hurtig H, Stern M, Weintraub D, Vaswani P, Willis AW, Siderowf A, Xie SX, Van Deerlin V, Chen-Plotkin AS. : Genetic and phenotypic characterization of Parkinson’s disease at the clinic-wide level. npj Parkinson's Disease 10(1): 97, May 2024.
Baldwin A, Copeland J, Azage M, Dratch L, Johnson K, Paul RA, Amado DA, Baer M, Deik A, Elman LB, Guo M, Hamedani AG, Irwin DJ, Lasker A, Orthmann-Murphy J, Quinn CC, Tropea TF, Scherer SS, Shinohara RT, Hamilton RH, Ellis CA: Disparities in Genetic Testing for Neurologic Disorders. Neurology 102(6), Mar 2024 Notes: https://doi.org/10.1212/WNL.0000000000209161.
Dratch L, Azage M, Baldwin A, Johnson K, Paul RA, Bardakjian TM, Michon SC, Amado DA, Baer M, Deik AF, Elman LB, Gonzalez-Alegre P, Guo MH, Hamedani AG, Irwin DJ, Lasker A, Orthmann-Murphy J, Quinn C, Tropea TF, Scherer SS, Ellis CA.: Genetic Testing in Adults with neurologic disorders: indications, approach, and clinical impacts. Journal of Neurology 217(2): 733-747, Feb 2024.
Deik A, Spindler M, Lasker A, Vaswani P, Aamodt W, Tropea T: A phase I/II open-label study to define the safety, tolerability and clinical activity of deutetrabenazine (AUstedo) in adult study subjects with DYsTonia (the AUDYT trial). PAS Congress 2024 in Cartagena, Colombia Feb 2024.
Allan Cole: Parkinson's and Palliative Care. PDwise.com Feb 2022.
Shaji A, M Solanki N, Ocasio Y, Kaur P, Muller E, Mendez A, Lasker A: Mindfulness Based Program for Newly Diagnosed Parkinson’s Patients. Movement Disorders Society, 2022, Annual Congress - Madrid 2022.
Shaji A, M Solanki N, Ocasio Y, Kaur P, Muller E, Mendez A, Lasker A: Mindfulness Based Program for Newly Diagnosed Parkinson’s Patients. American Neurological Association, 2022 Annual Meeting 2022.
Ashton C, Tacci C, Laracuente R, Sorberg E, Solis-Cohen L, Horn S, Lasker A, Vanderhorst V, Shih L: Spatio-temporal Analysis and Modeling of Gait in Parkinson’s Disease. American Neurological Association, Annual Meeting 2016 Notes: Lecturer and power-point slide developer.